current
practic
diagnosi
base
pcr
test
pharyng
respiratori
specimen
symptomat
patient
high
epidemiolog
risk
like
underestim
true
preval
infect
serolog
method
accur
estim
diseas
burden
detect
infect
miss
limit
test
perform
date
describ
valid
coronaviru
antigen
microarray
contain
immunolog
signific
antigen
addit
sarscov
merscov
common
human
coronaviru
strain
common
respiratori
virus
comparison
antibodi
profil
detect
array
control
sera
collect
prior
pandem
versu
convalesc
blood
specimen
virolog
confirm
case
demonstr
complet
discrimin
two
group
array
use
diagnost
tool
epidemiolog
tool
accur
estim
diseas
burden
research
tool
correl
antibodi
respons
clinic
outcom
background
caus
viru
worldwid
pandem
signific
morbid
mortal
estim
confirm
case
current
case
definit
confirm
infect
reli
pcrposit
pharyng
respiratori
specimen
test
larg
determin
presenc
fever
respiratori
symptom
individu
high
epidemiolog
risk
howev
case
definit
like
underestim
true
preval
individu
develop
subclin
infect
produc
fever
respiratori
symptom
unlik
test
test
pcr
pharyng
respiratori
specimen
around
sensit
depend
sampl
locat
techniqu
patient
viral
load
widespread
test
within
unit
state
also
sever
limit
lack
avail
test
kit
test
capac
limit
avail
public
privat
laboratori
therefor
true
preval
infect
like
much
higher
current
report
case
number
would
indic
serolog
play
import
role
defin
true
preval
particularli
subclin
infect
earli
studi
serolog
demonstr
high
sensit
detect
confirm
infect
antibodi
viru
detect
approxim
week
symptom
onset
unlik
pcr
posit
antibodi
detect
throughout
diseas
cours
persist
indefinit
multipl
serolog
test
develop
includ
recent
fdaapprov
later
flow
assay
howev
test
limit
detect
antibodi
one
two
antigen
crossreact
antibodi
human
coronavirus
present
adult
current
unknown
prior
use
serolog
detect
emerg
coronavirus
focus
antibodi
spike
protein
particularli
domain
nucleocapsid
n
protein
howev
optim
set
antigen
detect
strainspecif
coronaviru
antibodi
remain
unknown
protein
microarray
technolog
use
detect
antibodi
multipl
isotyp
hundr
antigen
high
throughput
manner
well
suit
serolog
surveil
studi
technolog
previous
appli
emerg
coronavirus
base
detect
bind
antibodi
wellcorrel
neutral
antibodi
requir
viral
cultur
biosafeti
level
facil
recent
group
develop
coronaviru
antigen
microarray
covam
includ
antigen
test
human
sera
collect
prior
pandem
demonstr
low
crossreact
antibodi
human
coronavirus
caus
common
cold
particularli
domain
valid
methodolog
use
convalesc
blood
specimen
case
confirm
posit
pcr
convalesc
blood
specimen
nasopharyng
pcrposit
individu
collect
differ
sourc
increas
number
posit
specimen
avail
analysi
two
sera
plasma
sampl
obtain
acut
patient
oregon
health
scienc
univers
hospit
ohsu
portland
sourc
discard
clinic
laboratori
specimen
exempt
inform
consent
irb
approv
condit
patient
anonym
four
plasma
sampl
obtain
outpati
univers
hospit
basel
univers
basel
basel
switzerland
patient
screen
accord
swiss
regul
blood
donat
approv
plasma
donor
accord
blood
transfus
servic
swiss
red
cross
inform
consent
donor
diagnos
base
posit
nasopharyng
swab
pcr
test
time
plasma
donat
two
neg
nasopharyng
swab
pcrtest
neg
pcr
test
blood
qualifi
plasma
donor
plasma
collect
convalesc
donor
region
blood
transfus
servic
swiss
red
cross
accord
nation
regul
one
convalesc
plasma
isol
largevolum
apheresi
collect
follow
standard
protocol
document
recov
blood
donor
day
post
symptomat
neg
control
sera
use
studi
collect
novemb
may
larger
studi
resid
colleg
resid
commun
eastern
unit
state
monitor
prospect
identifi
acut
respiratori
infect
ari
case
use
questionnair
rtqpcr
character
contagi
phenotyp
includ
social
connect
built
environ
immunolog
phenotyp
total
deidentifi
blood
specimen
test
cov
antigen
microarray
electron
inform
consent
includ
futur
research
use
author
obtain
protocol
approv
institut
review
board
irb
univers
maryland
depart
navi
human
research
protect
offic
coronaviru
antigen
microarray
use
investig
includ
antigen
across
subtyp
express
either
baculoviru
cell
tabl
antigen
provid
sino
inc
wayn
pa
either
catalog
product
custom
synthesi
servic
product
antigen
print
onto
microarray
probe
human
sera
analyz
previous
describ
briefli
lyophil
antigen
reconstitut
concentr
mgml
phosphatebuff
salin
pb
tpb
print
onto
nitrocelluloseco
slide
grace
bio
lab
gbl
bend
use
omnigrid
microarray
printer
genemachin
microarray
slide
probe
human
sera
dilut
gv
fast
block
buffer
fischer
scientif
overnight
wash
ttb
buffer
mm
trishcl
mm
nacl
adjust
ph
filter
time
minut
label
secondari
antibodi
human
iga
igg
conjug
quantum
dot
fluorophor
hour
room
temperatur
wash
ttb
time
minut
dri
slide
imag
use
arraycam
imag
grace
bio
lab
bend
measur
backgroundsubtract
median
spot
fluoresc
nonspecif
bind
secondari
antibodi
subtract
use
salin
control
mean
fluoresc
replic
spot
antigen
use
analysi
mean
fluoresc
intens
mfi
antigen
determin
averag
median
fluoresc
signal
four
replic
spot
fluoresc
signal
spot
determin
signal
intens
subtract
background
fluoresc
antigen
contain
human
fc
tag
remov
analysi
secondari
antibodi
use
quantif
known
bind
human
fc
nonhuman
fc
tag
interfer
assay
statist
analys
conduct
use
r
version
r
foundat
statist
comput
vienna
austria
mfi
normal
use
normalizequantilesusetarget
function
proprocesscor
packag
version
target
normal
vector
contain
median
mfi
igg
iga
construct
descript
statist
use
summar
iga
igg
reactiv
measur
mfi
wilcoxon
rank
sum
test
p
correct
multipl
comparison
use
compar
mean
differ
group
receiv
oper
characterist
area
curv
roc
auc
valu
antigen
calcul
compar
posit
neg
specimen
use
proc
packag
version
antigen
rank
base
roc
auc
valu
high
perform
antigen
roc
auc
identifi
data
visual
perform
use
packag
version
coronaviru
antigen
microarray
use
detect
igg
iga
antibodi
panel
antigen
includ
coronaviru
spike
protein
separ
receptorbind
rbd
domain
whole
protein
nucleocapsid
protein
np
multipl
coronavirus
includ
sarscov
merscov
four
common
cold
coronavirus
list
tabl
determin
antibodi
profil
infect
differenti
reactiv
antigen
evalu
convalesc
plasma
pcrposit
individu
posit
group
sera
collect
prior
pandem
individu
neg
group
shown
figur
posit
group
demonstr
high
igg
reactiv
np
antigen
moder
igg
reactiv
rbd
antigen
neg
group
demonstr
low
igg
crossreact
crossreact
antigen
figur
posit
group
also
demonstr
high
igg
crossreact
sarscov
np
merscov
antigen
neg
group
demonstr
low
crossreact
merscov
crossreact
sarscov
merscov
antigen
two
group
differ
significantli
reactiv
common
cold
coronavirus
season
circul
respiratori
virus
similar
trend
observ
iga
lower
reactiv
overal
figur
posit
group
demonstr
high
iga
reactiv
np
moder
iga
reactiv
high
iga
crossreact
sarscov
np
neg
group
demonstr
low
iga
crossreact
sarscov
merscov
antigen
coronaviru
antigen
evalu
perform
discrimin
posit
group
neg
group
across
full
rang
assay
cutoff
valu
gener
receiv
oper
characterist
roc
curv
area
curv
roc
auc
measur
figur
highperform
antigen
detect
igg
iga
defin
roc
auc
includ
antigen
merscov
igg
iga
tabl
antigen
discrimin
posit
group
neg
group
high
signific
figur
studi
reveal
sever
insight
antibodi
respons
infect
antibodi
profil
individu
includ
high
igg
reactiv
common
cold
coronavirus
lowlevel
crossreact
domain
epidem
coronavirus
surpris
given
high
degre
sequenc
homolog
previous
observ
serolog
crossreact
domain
betacoronavirus
group
includ
sarscov
mer
common
cold
coronavirus
howev
individu
show
crossreact
antigen
even
nucleocapsid
protein
also
high
sequenc
homolog
betacoronavirus
crossreact
seen
sarscov
merscov
common
cold
coronavirus
addit
quantit
differ
high
antibodi
reactiv
posit
group
lowlevel
antibodi
crossreact
neg
group
larg
enough
antigen
still
discrimin
group
high
signific
studi
also
inform
antigen
select
design
popul
surveil
clinic
diagnost
assay
vaccin
develop
observ
individu
antibodi
common
cold
coronavirus
show
crossreact
nucleocapsid
protein
dispel
concern
high
sequenc
homolog
protein
across
betacoronavirus
would
impair
perform
diagnost
vaccin
antigen
lowlevel
antibodi
crossreact
individu
spike
protein
contain
domain
may
preclud
use
diagnost
antigen
given
larg
quantit
differ
antibodi
reactiv
posit
neg
group
crossreact
may
influenc
respons
vaccin
spike
protein
antigen
contain
domain
coronaviru
antigen
microarray
use
epidemiolog
tool
research
tool
high
throughput
detect
antibodi
profil
reliabl
distinguish
case
neg
control
appli
largescal
popul
surveil
studi
accur
estim
true
preval
diseas
achiev
symptombas
pcr
test
addit
detect
antibodi
convalesc
plasma
donat
provid
valid
prior
clinic
use
passiv
immun
variat
antibodi
profil
among
acut
convalesc
donor
suggest
epitop
character
convalesc
donor
plasma
inform
evalu
passiv
immun
therapi
efficaci
patient
central
role
inflamm
pathogenesi
sever
close
studi
analyz
strainspecif
crossreact
antibodi
respons
particularli
test
hypothes
regard
antibodydepend
enhanc
critic
implic
vaccin
develop
coronaviru
antigen
microarray
contain
panel
antigen
addit
human
coronavirus
abl
reliabl
distinguish
convalesc
plasma
pcrposit
case
neg
control
sera
collect
prior
pandem
detect
strainspecif
crossreact
antibodi
studi
need
appli
methodolog
largescal
serolog
surveil
studi
correl
specif
antibodi
respons
clinic
outcom
coronaviru
antigen
microarray
intellectu
properti
regent
univers
california
licens
commerci
nanommun
inc
irvin
ca
privat
compani
philip
l
felgner
largest
sharehold
sever
coauthor
de
assi
jain
nakajima
jasinska
obiero
davi
khan
also
share
nanommun
inc
busi
partnership
sino
biolog
inc
beij
china
express
purifi
antigen
use
studi
convalesc
plasma
use
studi
collect
clinic
use
independ
blood
center
use
licens
plasma
platelet
process
system
manufactur
ceru
corpor
multipl
author
corash
bagri
sharehold
employe
manuel
battegay
andrea
buser
andrea
holbro
employe
univers
basel
conflict
interest
figur
heatmap
coronaviru
antigen
microarray
heatmap
show
igg
iga
b
reactiv
measur
mean
fluoresc
intens
across
four
replic
antigen
organ
row
color
code
viru
sera
organ
column
classifi
posit
convalesc
pcrposit
individu
neg
prior
pandem
individu
reactiv
repres
color
white
low
black
mid
red
high
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
figur
normal
igg
reactiv
posit
neg
sera
coronaviru
antigen
microarray
plot
show
igg
reactiv
antigen
measur
mean
fluoresc
intens
mfi
full
rang
bar
interquartil
rang
box
convalesc
sera
pcrposit
individu
posit
red
sera
individu
prior
pandem
neg
blue
plot
heatmap
show
averag
reactiv
group
white
low
black
mid
red
high
antigen
label
color
code
respiratori
viru
group
